Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD)

This study has been completed.
Information provided by:
Boehringer Ingelheim Identifier:
First received: September 9, 2005
Last updated: October 28, 2013
Last verified: October 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: December 2005
  Primary Completion Date: December 2005 (Final data collection date for primary outcome measure)